share_log

Moderna | 3: Initial statement of beneficial ownership of securities-Director Hussain Abbas

Moderna | 3: Initial statement of beneficial ownership of securities-Director Hussain Abbas

Moderna | 3：首次持股聲明-董事 Hussain Abbas
美股SEC公告 ·  10/04 08:54
Moomoo AI 已提取核心訊息
Moderna, Inc. (NASDAQ: MRNA) has reported a new filing with the United States Securities and Exchange Commission (SEC) on October 2, 2024. The Form 3, known as the Initial Statement of Beneficial Ownership of Securities, was submitted by Abbas Hussain, who is identified as a Director and a 10% Owner of the company. The filing, signed by Brian Sandstrom as Attorney-in-Fact on October 4, 2024, indicates that Hussain does not beneficially own any securities directly or indirectly, including derivative securities such as puts, calls, warrants, options, or convertible securities. This form is a standard requirement for new insiders of a publicly-traded company to report their ownership of the company's stock and is filed pursuant to Section 16(a) of the Securities Exchange Act of 1934.
Moderna, Inc. (NASDAQ: MRNA) has reported a new filing with the United States Securities and Exchange Commission (SEC) on October 2, 2024. The Form 3, known as the Initial Statement of Beneficial Ownership of Securities, was submitted by Abbas Hussain, who is identified as a Director and a 10% Owner of the company. The filing, signed by Brian Sandstrom as Attorney-in-Fact on October 4, 2024, indicates that Hussain does not beneficially own any securities directly or indirectly, including derivative securities such as puts, calls, warrants, options, or convertible securities. This form is a standard requirement for new insiders of a publicly-traded company to report their ownership of the company's stock and is filed pursuant to Section 16(a) of the Securities Exchange Act of 1934.
Moderna, Inc.（納斯達克：MRNA）已於2024年10月2日向美國證券交易委員會（SEC）提交了一份新的申報。這是稱爲Form 3的初始有價證券受益所有權聲明，由被確認爲該公司董事和10％所有者的阿巴斯·侯賽因提交。提交人Brian Sandstrom作爲代理人於2024年10月4日簽署了該申報，申明侯賽因無論是直接還是間接地擁有任何證券，包括認股權證、認購權、認股權、期權或可轉換證券等衍生證券。這一表格是公開交易公司的新內部人員報告他們對公司股票的所有權的標準要求，並根據1934年證券交易法第16（a）條提交。
Moderna, Inc.（納斯達克：MRNA）已於2024年10月2日向美國證券交易委員會（SEC）提交了一份新的申報。這是稱爲Form 3的初始有價證券受益所有權聲明，由被確認爲該公司董事和10％所有者的阿巴斯·侯賽因提交。提交人Brian Sandstrom作爲代理人於2024年10月4日簽署了該申報，申明侯賽因無論是直接還是間接地擁有任何證券，包括認股權證、認購權、認股權、期權或可轉換證券等衍生證券。這一表格是公開交易公司的新內部人員報告他們對公司股票的所有權的標準要求，並根據1934年證券交易法第16（a）條提交。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息